Content about Guy Quigley

October 9, 2012
Matrixx ups takeover bid of ProPhase to $1.60 per share

Matrixx Initiatives on Tuesday announced its second overture to ProPhase Labs with an increased acquisition offer of $1.60 per share.

September 17, 2012
ProPhase rejects Matrixx acquisition proposal

ProPhase Labs on Monday announced that it rejected an unsolicited, nonbinding proposal from Matrixx Initiatives to acquire the company for $1.40 per share in cash, subject to further due diligence by Matrixx.

© 2013 Drug Store News. All Rights Reserved.